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INTRODUCTION:  Retroperitoneal  tumors  are  rare,  mostly  malignant.  Locally  aggressive,  and  more  frequent
in women  in  their  5th  decade  of life. Its  symptoms  are  nonspeciﬁc,  including  abdominal  pain  and  palpable
mass.  To diagnosis  is helpful  computed  tomography  and  biopsy.  It needs  surgery  for  absolute  healing.
PRESENTATION  OF  CASE:  67 years  old  man  was  admitted  with  back  pain  and  fever.  Abdominal  imaging  tests
showed  a 15  cm  abdominal  mass  without  clear  organodependencia.  Endoscopy  with  biopsies  evidenced
mesenchymal  neoplasia  of  undetermined  origin.  In surgery  we  conﬁrm  its resecability  and  was  necessary
multiorgan  resection.  Pathologic  diagnosis:  well  differentiated  retroperitoneal  leiomyosarcoma.  Started
adjuvant  radiotherapy.  In subsequent  tests  showed  the  presence  of liver  metastases.
DISCUSSION:  Retroperitoneal  tumors  are  developed  from  nerve,  vascular,  muscular,  connective,  support-
ive and ﬁbroareolar  tissue  from  this  space.  Its  size  does  not  modiﬁcate  survival  or resectability.  We  used
TC and  biopsy  for its  diagnose.  Adjuvant  therapy  does  not  affect  survival  or  quality  of  life,  surgery  remains
the only  curative  option.  Locoregional  recurrence  is the  most  inﬂuential  ﬁgure  in  the  prognosis.  A  large
percentage  of patients  required  a  second  surgery  (between  45  and  82%).
CONCLUSION:  The  only  curative  option  of  retroperitoneal  sarcomas  is  surgery,  which  usually  requires  mul-
tiple organ  resection.  Chemotherapy  and  radiotherapy  are  mostly  a  surgical  supplement.  Chemotherapy
has  not  shown  signiﬁcant  increase  in survival.
©  2014  The  Authors.  Published  by  Elsevier  Ltd. on behalf  of Surgical  Associates  Ltd.  This  is an  open
access  article  under  the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).. Introduction
Retroperitoneal tumors represent a rare entity, most are malig-
ant and sarcomas are most commonly. Sarcomas are malignant
umors derived from embrionary mesoderm that arise from skele-
al and extraskeletal connective tissues, including the peripheral
ervous system. The majority of soft tissue sarcomas present in the
xtremities; however, many other sites can be affected, including
he retroperitoneum. Leiomyosarcomas are second in frequency at
his location, and also one of the most aggressive. More frecuent in
omen between the fourth and sixth decades of life.1 Most patients
ebut with abdominal pain, followed by palpable abdominal mass.
ymtomps of local compresion are less frequent. The diagnosis is
sually given by computerized tomography (CT) and biopsy.2
The only effective treatment known at the time is surgical
esection R0, since chemotherapy is used only in metastasis, and
adiotherapy is a surgical complement to decrease locoregional
ecurrence risk. To obtain surgical safe margin, is often necessary
he resection of another adjacent inﬁltrated organs.3 Recurrence,
∗ Corresponding author. Personal address: C/Antonio de Ulloa, n◦7. 1◦A, El Puerto
e  Santa María, 11500 Cádiz, Spain. Tel.: +34 630415001.
E-mail address: fasismateo@gmail.com (F. Mateo Vallejo).
ttp://dx.doi.org/10.1016/j.ijscr.2014.10.061
210-2612/© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associate
http://creativecommons.org/licenses/by-nc-nd/3.0/).which is the most important prognostic factor in these patients, is
very common.
We  present a case of retroperitoneal leiomyosarcoma where
was necessary multiorgan resection for its treatment.
2. Presentation of case
A 67 year old male was admitted for study of fever, back pain,
constitutional symptoms and general illness with several months
of evolution. During hospitalization the patient required repeated
transfusions because of progressive anemia, needing more than
twelve packed erythrocytes.
Physical examination revealed an abdominal mass in left upper
quadrant, hard and ﬁxed to deeper layers.
Ultrasound showed a enlarged spleen (14.5 cm)  with difﬁcult to
access to splenic hilum due to a 15 cm diameter, heterogeneous and
multi-lobed mass. Located above and medial to left kidney upper
pole and lateral to aorta, in intimate contact with posterior spleen
face. No involvement or liver metastasis was  observed.The admission CT report a tumor in left upper quadrant of 17 cm
in diameter, heterogeneous hypo-and hyperdense areas and gas in
superoanterior portion. Inﬁltrates spleen, left kidney and adrenal
gland, colon and pancreas, with no clear dependence of any of
s Ltd. This is an open access article under the CC BY-NC-ND license
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Fig. 1. Abdominal CT showing tumor located between spleen and stomach with
retroperitoneal inﬁltration.
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Fig. 2. Coronal CT image demonstrating the involvement of the whole area corre-
sponding to left upper quadrant of the abdomen.
Fig. 3. Surgical ﬁeld showing the affected area and the absence of local spread or
multiple peritoneal involvement.
Fig. 4. Piece of surgical resection including stomach, spleen, left transverse colonhese structures. The patient had gastrointestinal bleeding, thus
e did oral endoscopy with biopsy, which evidenced ulceration of
he gastric mucosa by extrinsic neoplasia. Biopsies were informed
s fusiform cell proliferation and mesenchymal neoplastic nature,
nable to determine its origin.
Debating exposure the case at the digestive tumors interdisci-
linary committee, it was decided practise an open mass biopsy,
fter which we had patologycal diagnosis: well differentiated
eiomyosarcoma. We decided not to perform percutaneous biopsy
ecause of the risk of spread and the low diagnostic sensitivity of
his technique in our hospital.
The patient was programed to an exploratory laparotomy to
ecided tumor resectability.
Planned surgery is based on the CT image, showing a dissec-
ion plane starting laterally to the left side of the spleen, behind
he pancreas neck, and including part of the colon with the trans-
erse mesocolon and stomach. During surgery we  conﬁrmed this
as possible and practiced block tumor removal, including full gas-
ric resection, spleen, pancreas and 20 cm distal transverse colon.
ntraoperative retroperitoneal tissue biopsy showed no inﬁltration
n renal or adrenal area.
We obtained a diagnosis of well-differentiated retroperitoneal
eiomyosarcoma that ulcerated stomach wall and inﬁltrated spleen,
ancreas and transverse colon serosa. Mitotic index of 15 mitoses
er 50 high power ﬁelds and surgical margins were free of disease.
etastasis was not noted on any of the lymph nodes removed.
Postoperatively, the patient presented a left retroperitoneal
bscess ﬁstulized to preexisting renal cyst, which require percu-
aneous drainage for its resolution.
As adjuvant treatment, the patient started radiotherapy. In sub-
equent image test, nine months later, there were evident liver
esions, and proceeded to ﬁne needle puncture-aspiration ultra-
ound guided, conﬁrming that those corresponded to metastasis.
hus began chemotherapy treatment with gemcitabine and doce-
axel, but lesions have not size reduction after six sessions, so the
atient currently continues with palliative chemotherapy and is
ollowed by Oncology Service. The patient died 23 months after
urgery (Figs. 1–5).
and pancreatic tail.
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Ethical approvalFig. 5. Surgical ﬁeld when resection was  completed.
. Discussion
The retroperitoneum is deﬁned anteriorly by the peritoneal
xtensions anchoring the transverse colon, the small bowel, and
he ascending and descending colon. The posterior aspect of this
pace is a muscular wall comprising the psoas major and minor, the
uadratus lumborum, obturator internus, pyriformis muscle and
he tendinous portion of the transversus abdominis muscle. The
etroperitoneum is bordered superiorly by the diaphragm, inferi-
rly by the levator ani muscles, and laterally by the ascending and
escending colon in combination with the peripheral margin of the
uadratus lumborum muscles.
Retroperitoneal tumors are deﬁned as those that are formed
rom nerve, vascular, muscular, connective, supportive and
broareolar tissue, excluding organs and great vessels that are in
his space. At this level 85% of tumors are malignant, and of these,
0% are sarcomas.4 The most common subtypes of sarcomas at this
evel are liposarcoma, with the best prognosis, and leiomyosarco-
as, one of the most aggressive.
The average size of these tumors at diagnosis is 16 cm,  since
hey do not start giving symptoms until they reach 10 cm in diam-
ter. The retroperitoneum has adaptability, allowing tumor growth
ithout the rest of the body perceiving changes. Its growth is slow
nd insidious. However, size is not an impediment to total resection
either data for worse survival.5 Tumor growth is centrifugal, being
he most immature cells in the outer layer of the tumor, compress-
ng surrounding structures.
The symptoms presented by these tumors are nonspeciﬁc and
aried, depending on the affected organ and its location.6 The
ost common symptoms are abdominal or back pain, and palpable
bdominal mass. Usually also present gastrointestinal disorders,
rinary discomfort, lower limb edema, sweating or constitutional
ymptoms.
For the diagnosis, the most sensitive imaging test and higher
erformance is CT. It can help determinate histological tumor type
ecause of the indirect data (necrotic areas, fat or muscle tissue),7
elps to delineate the tumor and its relationship to other structures,
istinguishing between invasion or contact; staged the tumor,
ecause it shows node and distant metastases, and sometimes pro-
ides information of the origin of the tumor. puncture/biopsy is
ommonly used for diagnosis, but is more reliable if it is guided by
mage tests, CT, as otherwise can be inconclusive.3The use of adjuvant therapy has not demonstrated to increase
urvival neither provide a better quality of life. Surgery is the only
rocedure that has proven to be curative.PEN  ACCESS
urgery Case Reports 5 (2014) 1050–1053
It needs a complete microscopic tumor resection R0 for an
acceptable survival as locoregional recurrence is the most inﬂuen-
tial data in the prognosis. Recurrences can occur more frequently in
incomplete resections (macro or microscopic). For complete tumor
resection is necessary removing neighbors organs by more than
50% of the time, the most frequently resected organs are kidney
and adrenal gland, but pancreas, spleen, liver, colon, duodenum
and cava are also affected on numerous occasions. These resections
imply increased morbidity though to mortality, and longer and
more complex surgeries. Pancreatic manipulation (total sections
and especially partial) increases the risk of complications espe-
cially postoperatively. Sometimes different specialists are required
for resection the different inﬁltrated structures by the tumor.
Resectability tumor can only be conﬁrmed during surgery, and
when it is not possible, is usually to do extensive inﬁltration of
the mesenteric root, neurovascular extensive inﬁltration, distant
metastasis or peritoneal sarcomatosis.8
Complete resection was achieved in only 39% of cases in some
series.
Nodal metastases and tumor size, have not prognostic sig-
niﬁcance, provided they can be removed in opposite to distant
metastases, which are usually caused by hematogenous dissem-
ination. The presence of distant metastasis should not suggest a
palliative treatment, if it can be completely removed both the orig-
inal tumor and metastasis. Resection of metastases after surgery is
necessary if you want to increase patient survival.9
A large percentage of patients with R0 resection require rescue
surgery (between 45 and 82%).10 Posterior median survival is under
10 months. In nonresecable tumors patients, the median survival
is lower than 6 months. Patients with complete resection, which
do not require subsequent surgery have an average survival of 5
years.11
4. Conclusions
Currently, surgery is the only “curative” option for retroperi-
toneal sarcomas. Before surgery, image tests are needed to
delineate the tumor and the affected organs to prepare a good
surgical strategy that sometimes require more than one special-
ist. Because the tumor at diagnosis is usually voluminous, wide
approaches are preferred, especially if it requires multiple organ
resection.
Aggressive surgical treatment is justiﬁed only in patients in
which complete tumor resection is feasible. In our patient, the
resection was carried out with curative intent to attempt to
improve his quality of life severely limited by persistent anemia.
The patient survived 23 months after surgery with an acceptable
quality of life.
Chemotherapy and radiotherapy are in most cases a surgical
complement although chemotherapy has not demonstrated a sig-
niﬁcant increase in survival.
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